E. Krognes - Feb 29, 2024 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Director
Signature
/s/ John Saia, as attorney-in-fact for Steve Krognes
Stock symbol
GH
Transactions as of
Feb 29, 2024
Transactions value $
$0
Form type
4
Date filed
3/1/2024, 05:08 PM
Previous filing
Feb 15, 2024
Next filing
Apr 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Options Exercise $0 +154 +5.25% $0.00 3.09K Feb 29, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Restricted Stock Units Options Exercise $0 -154 -3.44% $0.00 4.32K Feb 29, 2024 Common Stock 154 $0.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents a restricted stock unit award granted on August 9, 2022 that vests as to 25% of the shares subject to such award on June 30, 2023, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of June 30, 2023, during the three-year period thereafter.
F2 Not applicable for Restricted Stock Units.